ASTS
AST SpaceMobile, Inc.
ASTS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
SCSC
ScanSource, Inc.
SCSC has the edge over ASTS overall, supported by lower modeled downside and stronger modeled upside.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SCSC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Healthy |
SCSC's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
SCSC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.7x | $27.69 | -37% |
| Forward | 8.9x | $44.26 | — |
| Fair | 13x | $42.03 | -5% |
| Current | 14x | $44.26 | — |
| Expensive | 17x | $52.71 | +19% |
Historical ranges are pointers, not guarantees.
SCSC's PE is in its fair range at 14x. If earnings grow as analysts expect, today's price would be 8.9x next year's earnings, in its cheap range.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
SCSC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for SCSC, with profitability holding steady.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
SCSC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.00 | +58% |
| Q3 2026 | $3.17 | -0.9% |
| Q2 2026 | $3.64 | +21% |
| Q1 2026 | $3.29 | +18% |
| Q4 2025 | $3.25 | +27% |
| Q3 2025 | $3.20 | +1.9% |
| Q2 2025 | $3.00 | -2% |
| Q1 2025 | $2.79 | -12% |
| Q4 2024 | $2.55 | -27% |
SCSC has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over SCSC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
SCSC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $962.3M | +30% |
| Q2 2026 | $953.1M | +17% |
| Q1 2026 | $766.8M | +8.8% |
| Q4 2025 | $766.5M | +2.5% |
| Q3 2025 | $739.7M | -4.6% |
| Q2 2025 | $812.9M | +8.9% |
| Q1 2025 | $704.8M | -6.3% |
| Q4 2024 | $747.5M | -16% |
SCSC's revenue has grown year over year for four quarters in a row: $962M last quarter, up 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.3% | -2.2 points |
| Q2 2026 | 3.3% | 0 points |
| Q1 2026 | 3% | -0.1 points |
| Q4 2025 | 2.3% | -0.1 points |
| Q3 2025 | 3.5% | +1.2 points |
| Q2 2025 | 3.3% | +0.4 points |
| Q1 2025 | 3.2% | +0.8 points |
| Q4 2024 | 2.5% | -0.6 points |
SCSC has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
SCSC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$44.1M | -312% |
| Q2 2026 | -$4.8M | -193% |
| Q1 2026 | $69M | +6.7% |
| Q4 2025 | $28.9M | +$37M |
| Q3 2025 | $20.8M | -51% |
| Q2 2025 | $5.1M | -90% |
| Q1 2025 | $64.6M | -59% |
| Q4 2024 | -$8.2M | -113% |
SCSC has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
SCSC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.6% | -1M shares |
| 1 year | -7.7% | -1.7M shares |
| 3 years | -18% | -4.5M shares |
| 5 years | -20% | -5M shares |
| Available history | -18% | -4.7M shares |
SCSC has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.8M |
| Q2 2026 | $26.5M |
| Q1 2026 | $32.7M |
| Q4 2025 | $17.4M |
| Q3 2025 | $21.3M |
| Q2 2025 | $25.3M |
| Q1 2025 | $28.9M |
| Q4 2024 | $24.2M |
SCSC spent $81M buying back its own shares over the past year, down 18% from the year before.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SCSC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | 0.1x | Very low |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 0.3x | Very low |
SCSC's net debt is less than a year of its operating earnings (EBITDA).
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
SCSC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.4 | Neutral |
| Stochastic | 24.2 | Neutral |
SCSC's weekly RSI is 37 (neutral) and its Stochastic is 24 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
SCSC PE vs Technology Sector
| Metric | SCSC | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 28x | 50% below |
| PE % | 53 | 35 | 18 pts above |
SCSC is trading at 14x earnings, a 50% discount to the Technology sector's median of 28x.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
SCSC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $55.9 | 21% below |
| 20 week MA | $55.5 | 20% below |
| 50 week MA | $46.8 | 5.4% below |
| 100 week MA | $43.8 | 1.1% above |
| 200 week MA | $41.0 | 7.9% above |
SCSC has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
SCSC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.6 | $26.2 | -28% |
| 2021 | $26.2 | $34.6 | +32% |
| 2022 | $34.6 | $29.1 | -16% |
| 2023 | $29.1 | $39.6 | +36% |
| 2024 | $39.6 | $47.8 | +21% |
| 2025 | $47.8 | $39.7 | -17% |
| 2026 YTD | $39.7 | $44.3 | +11% |
SCSC has the edge over ASTS on returns for 2026, with the stronger performance.